Investment analysts at StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a research note issued to investors on Tuesday. The firm set a “hold” rating on the biotechnology company’s stock.
Calithera Biosciences Stock Performance
CALA opened at $0.01 on Tuesday. Calithera Biosciences has a 12-month low of $0.01 and a 12-month high of $0.50. The stock has a fifty day moving average of $0.02 and a 200-day moving average of $0.03.
Calithera Biosciences Company Profile
Read More
- Five stocks we like better than Calithera Biosciences
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- The Top 3 Sectors Poised For Growth This Summer
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- U.S. Steel Stock: Betting on EPS Cut and Merger Uncertainty?
- What Investors Need to Know to Beat the Market
- GitLab Stock: Pioneering the AI-Powered DevSecOps Platform
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.